Matches in SemOpenAlex for { <https://semopenalex.org/work/W2615639531> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2615639531 endingPage "3080" @default.
- W2615639531 startingPage "3071" @default.
- W2615639531 abstract "The aim of this dose-response study was to compare the effectiveness of 10 mg, 20 mg, and 40 mg of pantoprazole with that of placebo tablets in the healing and symptom relief of gastroesophageal reflux disease associated with erosive esophagitis, and to determine the optimal dose.A total of 603 patients with endoscopically confirmed (Hetzel-Dent scale) erosive esophagitis of grade 2 (64.5%) or grades 3 or 4 (35.3%) were enrolled in a double-blind, multicenter study and randomly assigned to receive pantoprazole (10 mg, 20 mg, or 40 mg) or placebo, administered once daily in the morning, for 4 or 8 wk depending on healing.The healing rates after 4 wk for placebo and pantoprazole 10 mg, 20 mg, and 40 mg/day were 14%, 42%, 55%, and 72%, respectively (p < 0.001 for all doses of pantoprazole vs placebo). Cumulative healing rates after 8 wk for placebo and pantoprazole 10 mg, 20 mg, and 40 mg/day were 33%, 59%, 78%, and 88%, respectively (p < 0.001 for all doses of pantoprazole vs placebo). The 40-mg pantoprazole dose produced greater rates of healing and earlier healing of esophagitis than either the 10- or 20-mg dose, regardless of severity. Pantoprazole, at any dose, was significantly more effective than placebo in relieving reflux symptoms. Patients on pantoprazole 40 mg experienced relief of symptoms on day 1 of treatment. No serious treatment-related adverse events occurred.Pantoprazole was safe and effective for healing erosive esophagitis and provided rapid symptomatic relief. These results indicate that pantoprazole offers a new option for treatment of erosive esophagitis. Among the three doses studied, the 40-mg dose was the most effective." @default.
- W2615639531 created "2017-05-26" @default.
- W2615639531 creator A5011290043 @default.
- W2615639531 creator A5061045517 @default.
- W2615639531 date "2000-11-01" @default.
- W2615639531 modified "2023-09-25" @default.
- W2615639531 title "Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial" @default.
- W2615639531 cites W1530382242 @default.
- W2615639531 cites W1658956668 @default.
- W2615639531 cites W1980892437 @default.
- W2615639531 cites W1985636157 @default.
- W2615639531 cites W1987496466 @default.
- W2615639531 cites W2010621040 @default.
- W2615639531 cites W2043120893 @default.
- W2615639531 cites W2089454236 @default.
- W2615639531 cites W2123323260 @default.
- W2615639531 cites W2126705325 @default.
- W2615639531 cites W2129255457 @default.
- W2615639531 cites W2130049076 @default.
- W2615639531 cites W2156436733 @default.
- W2615639531 cites W2170838928 @default.
- W2615639531 doi "https://doi.org/10.1111/j.1572-0241.2000.03254.x" @default.
- W2615639531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11095320" @default.
- W2615639531 hasPublicationYear "2000" @default.
- W2615639531 type Work @default.
- W2615639531 sameAs 2615639531 @default.
- W2615639531 citedByCount "91" @default.
- W2615639531 countsByYear W26156395312012 @default.
- W2615639531 countsByYear W26156395312017 @default.
- W2615639531 countsByYear W26156395312018 @default.
- W2615639531 countsByYear W26156395312019 @default.
- W2615639531 countsByYear W26156395312022 @default.
- W2615639531 countsByYear W26156395312023 @default.
- W2615639531 crossrefType "journal-article" @default.
- W2615639531 hasAuthorship W2615639531A5011290043 @default.
- W2615639531 hasAuthorship W2615639531A5061045517 @default.
- W2615639531 hasConcept C126322002 @default.
- W2615639531 hasConcept C142724271 @default.
- W2615639531 hasConcept C168563851 @default.
- W2615639531 hasConcept C197934379 @default.
- W2615639531 hasConcept C204787440 @default.
- W2615639531 hasConcept C27081682 @default.
- W2615639531 hasConcept C2777498785 @default.
- W2615639531 hasConcept C2779134260 @default.
- W2615639531 hasConcept C2779920096 @default.
- W2615639531 hasConcept C2781315423 @default.
- W2615639531 hasConcept C43270747 @default.
- W2615639531 hasConcept C71924100 @default.
- W2615639531 hasConcept C90924648 @default.
- W2615639531 hasConceptScore W2615639531C126322002 @default.
- W2615639531 hasConceptScore W2615639531C142724271 @default.
- W2615639531 hasConceptScore W2615639531C168563851 @default.
- W2615639531 hasConceptScore W2615639531C197934379 @default.
- W2615639531 hasConceptScore W2615639531C204787440 @default.
- W2615639531 hasConceptScore W2615639531C27081682 @default.
- W2615639531 hasConceptScore W2615639531C2777498785 @default.
- W2615639531 hasConceptScore W2615639531C2779134260 @default.
- W2615639531 hasConceptScore W2615639531C2779920096 @default.
- W2615639531 hasConceptScore W2615639531C2781315423 @default.
- W2615639531 hasConceptScore W2615639531C43270747 @default.
- W2615639531 hasConceptScore W2615639531C71924100 @default.
- W2615639531 hasConceptScore W2615639531C90924648 @default.
- W2615639531 hasIssue "11" @default.
- W2615639531 hasLocation W26156395311 @default.
- W2615639531 hasLocation W26156395312 @default.
- W2615639531 hasOpenAccess W2615639531 @default.
- W2615639531 hasPrimaryLocation W26156395311 @default.
- W2615639531 hasRelatedWork W1969964175 @default.
- W2615639531 hasRelatedWork W1982494163 @default.
- W2615639531 hasRelatedWork W2001782466 @default.
- W2615639531 hasRelatedWork W2011370817 @default.
- W2615639531 hasRelatedWork W2072357468 @default.
- W2615639531 hasRelatedWork W2089617885 @default.
- W2615639531 hasRelatedWork W2615639531 @default.
- W2615639531 hasRelatedWork W2896086209 @default.
- W2615639531 hasRelatedWork W3116896978 @default.
- W2615639531 hasRelatedWork W2741043795 @default.
- W2615639531 hasVolume "95" @default.
- W2615639531 isParatext "false" @default.
- W2615639531 isRetracted "false" @default.
- W2615639531 magId "2615639531" @default.
- W2615639531 workType "article" @default.